Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study

PURPOSE: We hypothesized that granulocyte-macrophage colony-stimulating factor (GM-CSF) could potentiate the clinical activity of rituximab, given their individual and cooperative effects on FcγRIIa- and FcγRIIIa-expressing cells. A phase II clinical study combining GM-CSF and rituximab was initiate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cartron, Guillaume, Zhao-Yang, Lu, Baudard, Marion, Kanouni, Tarik, Rouillé, Valérie, Quittet, Philippe, Klein, Bernard, Rossi, Jean-Francois
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2443403/
https://ncbi.nlm.nih.gov/pubmed/18427151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.7729
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi